Definiens and Cenix BioScience Enter into Licensing and Co-Marketing Agreement in High-Content Screening
As Cenix has constantly sought to further strengthen its capabilities in microscopy-based screening and automated image analysis, its scientists have tested a wide range of third party solutions from academia and industry efforts alike. Its early analysis of Cellenger® software in the context of genome-scale RNAi-based screens in human cells convinced Cenix to invest further efforts in assisting Definiens with the development and marketing of this world-class package.
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.